Avestar Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $628K | Sell |
7,219
-1,058
| -13% | -$101K | 0.04% | 302 |
|
|
2025
Q4 | $795K | Buy |
8,277
+251
| +3% | +$24.4K | 0.05% | 260 |
|
|
2025
Q3 | $764K | Sell |
8,026
-480
| -6% | -$44.1K | 0.05% | 270 |
|
|
2025
Q2 | $746K | Buy |
8,506
+2,125
| +33% | +$180K | 0.05% | 263 |
|
|
2025
Q1 | $578K | Buy |
6,381
+453
| +8% | +$40.5K | 0.05% | 264 |
|
|
2024
Q4 | $474K | Buy |
5,928
+815
| +16% | +$70.6K | 0.04% | 300 |
|
|
2024
Q3 | $460K | Buy |
5,113
+88
| +2% | +$7.4K | 0.05% | 267 |
|
|
2024
Q2 | $396K | Buy |
5,025
+542
| +12% | +$44.4K | 0.04% | 285 |
|
|
2024
Q1 | $391K | Buy |
4,483
+1,684
| +60% | +$144K | 0.04% | 277 |
|
|
2023
Q4 | $232K | Sell |
2,799
-1,115
| -28% | -$85K | 0.03% | 336 |
|
|
2023
Q3 | $307K | Buy |
3,914
+730
| +23% | +$61.1K | 0.04% | 245 |
|
|
2023
Q2 | $281K | Buy |
3,184
+189
| +6% | +$16.3K | 0.04% | 243 |
|
|
2023
Q1 | $243K | Buy |
+2,995
| New | +$244K | 0.04% | 265 |
|
|
2022
Q4 | – | Sell |
-6,100
| Closed | -$493K | – | 332 |
|
|
2022
Q3 | $493K | Buy |
6,100
+378
| +7% | +$34K | 0.13% | 122 |
|
|
2022
Q2 | $514K | Sell |
5,722
-42
| -0.7% | -$4.26K | 0.13% | 120 |
|
|
2022
Q1 | $640K | Sell |
5,764
-118
| -2% | -$12.5K | 0.1% | 183 |
|
|
2021
Q4 | $612K | Buy |
5,882
+278
| +5% | +$32.2K | 0.07% | 220 |
|
|
2021
Q3 | $702K | Buy |
5,604
+54
| +1% | +$6.99K | 0.09% | 230 |
|
|
2021
Q2 | $692K | Buy |
5,550
+29
| +0.5% | +$3.64K | 0.09% | 232 |
|
|
2021
Q1 | $724K | Sell |
5,521
-132
| -2% | -$15.5K | 0.16% | 132 |
|
|
2020
Q4 | $665K | Buy |
5,653
+51
| +0.9% | +$5.61K | 0.18% | 105 |
|
|
2020
Q3 | $605K | Sell |
5,602
-106
| -2% | -$10.6K | 0.2% | 108 |
|
|
2020
Q2 | $526K | Sell |
5,708
-78
| -1% | -$7.48K | 0.23% | 99 |
|
|
2020
Q1 | $525K | Sell |
5,786
-317
| -5% | -$33.7K | 0.29% | 86 |
|
|
2019
Q4 | $692K | Sell |
6,103
-59
| -1% | -$6.47K | 0.39% | 61 |
|
|
2019
Q3 | $669K | Buy |
6,162
+1,368
| +29% | +$143K | 0.42% | 55 |
|
|
2019
Q2 | $443K | Hold |
4,794
| – | – | 0.28% | 66 |
|
|
2019
Q1 | $414K | Sell |
4,794
-7
| -0.1% | -$627 | 0.27% | 66 |
|
|
2018
Q4 | $412K | Sell |
4,801
-4
| -0.1% | -$374 | 0.28% | 64 |
|
|
2018
Q3 | $446K | Sell |
4,805
-145
| -3% | -$13.4K | 0.26% | 61 |
|
|
2018
Q2 | $399K | Buy |
4,950
+389
| +9% | +$32.5K | 0.25% | 64 |
|
|
2018
Q1 | $341K | Buy |
4,561
+102
| +2% | +$8.41K | 0.22% | 63 |
|
|
2017
Q4 | $336K | Buy |
+4,459
| New | +$357K | 0.25% | 57 |
|
Other funds holding MDT
VCM
VPM
Avestar Capital's MDT Position: Q1 2026 in Review
Avestar Capital reduced its Medtronic (MDT) stake by 13% in Q1 2026, selling an estimated $101K and leaving 7,219 shares worth $628K. The position accounts for 0.04% of the portfolio, ranked #302.
Avestar Capital first reported a position in MDT in Q4 2017 and has held it in 33 quarters since. The position peaked at $795K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Avestar Capital held 7,219 shares of Medtronic worth $628K as of Q1 2026.
- Avestar Capital sold 1,058 Medtronic shares in Q1 2026, an estimated $101K.
- Medtronic made up 0.04% of Avestar Capital's portfolio in Q1 2026, its #302 holding.
- Avestar Capital first reported a position in Medtronic in Q4 2017 and has held it in 33 quarters since.
- Avestar Capital's Medtronic position peaked at $795K in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.